Skip to content

Drug interactions

Granisetron + Pasireotide

Severity: Moderate

Granisetron and Pasireotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide can prolong QT and cause bradycardia, and granisetron can add a small QT effect. Together they may raise the risk of torsade de pointes, particularly with hypokalemia or bradycardia.

What this interaction means in plain words

Granisetron and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Granisetron belongs to Gastrointestinal Tract; Pasireotide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive QT prolongation, with pasireotide-related bradycardia further increasing susceptibility.

What to do

Get a baseline ECG and correct potassium and magnesium. Repeat ECG monitoring when starting the combination in patients with cardiac risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Granisetron and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Granisetron with Pasireotide?

MediHelp rates the interaction as moderate. Granisetron and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide can prolong QT and cause bradycardia, and granisetron can add a small QT effect. Together they may raise the risk of torsade de pointes, particularly with hypokalemia or bradycardia.

How serious is the interaction between Granisetron and Pasireotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Get a baseline ECG and correct potassium and magnesium. Repeat ECG monitoring when starting the combination in patients with cardiac risk factors.

What other medicines interact with Granisetron?

MediHelp also lists interactions of Granisetron with, for example, Apomorphine, Amiodarone, Amisulpride. The full list is on the Granisetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in